BioSpace News Archive

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics, announced that it is engaged in a process to explore strategic alternatives to maximize shareholder value.

Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator of healthcare technology solutions, is proud to announce the approval of U.S. Patent 11,587,423, issued on February 21, 2023.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the 10th Gene Quantification Event held March 20-24 at the Technical University of Munich.

Bayer and Kimitec announced a new strategic partnership focused on accelerating the development and commercialization of biological crop protection solutions and biostimulants.

CancerVAX, Inc. announced that its sponsored research program with the University of California Los Angeles to research and develop a universal cancer vaccine is now fully under way.

Bioretec Ltd has published its 2022 Annual Report, Report by the Board of Directors, and Financial Statements.

Ryan Mitchell, PhD and Director of Business Development at Satellos to highlight SAT-3153 and Satellos’ novel muscle regeneration technology in two forums at this year’s MDA Conference and Summit

DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented a pooled analysis today from two clinical studies evaluating the performance of the company’s device in detecting skin cancer.

Bioretec Ltd’s Board of Directors has decided to reschedule the date of the company’s Annual General Meeting planned for April 14, 2023.

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the fourth quarter 2022 after market close on March 23, 2023.